I'd say that this requirement to continue 4C reporting is because of really sloppy reporting last year. I voiced some concerns at the time in
https://hotcopper.com.au/threads/ann-relief-from-quarterly-cash-flow-reporting.4669129/page-10?post_id=37723593 and
https://hotcopper.com.au/threads/ann-relief-from-quarterly-cash-flow-reporting.4669129/page-13?post_id=37724493
Also when you compared the June Q 4C YTD figures and added the September Q 4C quarterly figures they were way way out of whack with the September Q YTD figures.
Jun Q YTD Sept Q Should be Reported YTD in 4C Variance 1 Receipts 3595 6965 plus 2908 9873 8936 -937 2 R&D 261 542 plus 28 570 482 88 3 Product 821 1167 plus 1113 2280 2748 -468 4 Advertising 523 1111 plus 380 1491 1599 -100 5 Leased 0 plus 0 0 0 0 6 Staff 1204 2149 plus 984 3133 2459 674 7 Admin 534 1290 plus 397 1687 1839 -152 8 Interest 5 7 plus 1 8 8 0 9 Net Cash 257 713 plus 7 720 -183 -903
So all those variances are just errors which were submitted to the ASX and signed off on. I would not be surprised if a new September 4C was lodged shortly.
Further if the YTD Net Cash from operating is $-183k in September then there is no way you could get 4 consecutive cash flow statements by December. So the relief from cash flow reporting based on that aspect should be withdrawn, and has.
Personally I am excited to get 4C's again, I think it will be great to see the progress. I don't mind saying I am a bit skeptical about some of the brands and partners we have, its a great opportunity to see if they are making money.
- Forums
- ASX - By Stock
- AB1
- Ann: Quarterly Cash Flow Reporting
Ann: Quarterly Cash Flow Reporting, page-6
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
Add AB1 (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EL8
ELEVATE URANIUM LTD
Murray Hill, MD & CEO
Murray Hill
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online